Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.

Li Q, Kumar R, Underwood K, O'Connor AE, Loveland KL, Seehra JS, Matzuk MM.

Mol Hum Reprod. 2007 Sep;13(9):675-83. Epub 2007 Aug 18.

PMID:
17704537
2.

Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.

Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM.

Mol Endocrinol. 1996 May;10(5):534-43.

PMID:
8732684
3.

Genetic engineering to study testicular tumorigenesis.

Yan W, Burns KH, Matzuk MM.

APMIS. 2003 Jan;111(1):174-81; discussion 182-3. Review.

PMID:
12760377
4.

Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.

Cipriano SC, Chen L, Kumar TR, Matzuk MM.

Endocrinology. 2000 Jul;141(7):2319-27.

PMID:
10875231
5.

SMAD3 regulates gonadal tumorigenesis.

Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM.

Mol Endocrinol. 2007 Oct;21(10):2472-86. Epub 2007 Jun 26.

PMID:
17595316
6.

Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.

Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM.

Mol Endocrinol. 1999 Jun;13(6):851-65.

PMID:
10379885
7.

Role of androgens in testicular tumor development in inhibin-deficient mice.

Shou W, Woodruff TK, Matzuk MM.

Endocrinology. 1997 Nov;138(11):5000-5.

PMID:
9348231
8.

Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.

Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ.

Recent Prog Horm Res. 1996;51:123-54; discussion 155-7. Review.

PMID:
8701077
9.

Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.

Rajanahally S, Agno JE, Nalam RL, Weinstein MB, Loveland KL, Matzuk MM, Li Q.

Reprod Biol Endocrinol. 2010 Jun 21;8:69. doi: 10.1186/1477-7827-8-69.

10.

Identification of an inhibin receptor in gonadal tumors from inhibin alpha-subunit knockout mice.

Draper LB, Matzuk MM, Roberts VJ, Cox E, Weiss J, Mather JP, Woodruff TK.

J Biol Chem. 1998 Jan 2;273(1):398-403.

11.

Regulation of FSHbeta and GnRH receptor gene expression in activin receptor II knockout male mice.

Kumar TR, Agno J, Janovick JA, Conn PM, Matzuk MM.

Mol Cell Endocrinol. 2003 Dec 30;212(1-2):19-27.

PMID:
14654247
12.

Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.

Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJ.

Mol Endocrinol. 1994 Aug;8(8):983-95.

PMID:
7997239
13.

Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.

Gold E, Marino FE, Harrison C, Makanji Y, Risbridger G.

J Pathol. 2013 Mar;229(4):599-607. doi: 10.1002/path.4142. Epub 2013 Jan 25.

PMID:
23180294
14.

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.

Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.

Nature. 2000 Mar 23;404(6776):411-4.

PMID:
10746731
15.

Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system.

del Re E, Sidis Y, Fabrizio DA, Lin HY, Schneyer A.

J Biol Chem. 2004 Dec 17;279(51):53126-35. Epub 2004 Oct 8.

16.
17.
18.

Inhibin and p27 interact to regulate gonadal tumorigenesis.

Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM.

Mol Endocrinol. 2001 Jun;15(6):985-96.

PMID:
11376116
19.

An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.

Harrison CA, Gray PC, Fischer WH, Donaldson C, Choe S, Vale W.

J Biol Chem. 2004 Jul 2;279(27):28036-44. Epub 2004 Apr 27.

20.

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice.

Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A.

Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8817-21.

Supplemental Content

Support Center